Ryou Ishikawa

709 total citations
45 papers, 487 citations indexed

About

Ryou Ishikawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ryou Ishikawa has authored 45 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 9 papers in Surgery. Recurrent topics in Ryou Ishikawa's work include Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Ryou Ishikawa is often cited by papers focused on Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). Ryou Ishikawa collaborates with scholars based in Japan, China and United States. Ryou Ishikawa's co-authors include Reiji Haba, Kyuichi Kadota, Hiroyasu Yokomise, Emi Ibuki, Yoshio Kushida, Tetsuhiko Go, Norimitsu Kadowaki, Kosuke Inoue, Tomoya Ishii and Tohru Teraoka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Nutrients.

In The Last Decade

Ryou Ishikawa

39 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryou Ishikawa Japan 12 259 104 101 89 66 45 487
Rami Darwich Canada 10 35 0.1× 127 1.2× 32 0.3× 42 0.5× 29 0.4× 18 334
Thomas Aschacher Austria 13 123 0.5× 81 0.8× 43 0.4× 104 1.2× 18 0.3× 32 426
Alexandra Corina Faur Romania 10 42 0.2× 103 1.0× 15 0.1× 102 1.1× 30 0.5× 32 296
Emmy Yanagita Japan 13 71 0.3× 94 0.9× 25 0.2× 51 0.6× 37 0.6× 20 328
Peiqing Ma China 9 64 0.2× 72 0.7× 20 0.2× 49 0.6× 46 0.7× 14 287
Zhengming Zhu China 12 160 0.6× 124 1.2× 11 0.1× 73 0.8× 22 0.3× 30 360
Yuan Peng China 11 75 0.3× 86 0.8× 10 0.1× 56 0.6× 11 0.2× 33 314
Bofang Wang China 10 131 0.5× 90 0.9× 7 0.1× 40 0.4× 11 0.2× 39 325

Countries citing papers authored by Ryou Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Ryou Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryou Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryou Ishikawa more than expected).

Fields of papers citing papers by Ryou Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryou Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryou Ishikawa. The network helps show where Ryou Ishikawa may publish in the future.

Co-authorship network of co-authors of Ryou Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ryou Ishikawa. A scholar is included among the top collaborators of Ryou Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryou Ishikawa. Ryou Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ibuki, Emi, et al.. (2024). Case report: Para-testicular spindle cell lipoma suspected of well-differentiated liposarcoma. SHILAP Revista de lepidopterología. 4. 1400674–1400674.
2.
Li, Xiaodong, Zhixin Zhao, Ryou Ishikawa, et al.. (2024). Therapeutic Effect of Proteinase-Activated Receptor-1 Antagonist on Colitis-Associated Carcinogenesis. Cellular and Molecular Gastroenterology and Hepatology. 18(1). 105–131. 3 indexed citations
3.
Kanaji, Nobuhiro, Noriyuki Misaki, Makiko Murota, et al.. (2024). Prevalence and clinical features of interstitial lung disease in patients with psoriasis. BMC Pulmonary Medicine. 24(1). 610–610.
4.
Yoshida, Chihiro, et al.. (2024). Siglec10 Expression on Tumor-associated Macrophages Is an Independent Prognostic Factor in Stage I Lung Adenocarcinoma. Anticancer Research. 44(3). 1289–1297. 1 indexed citations
5.
Inoue, Kosuke, et al.. (2023). Subtyping of Non-Small Cell Lung Carcinoma into Adenocarcinoma and Squamous Cell Carcinoma by Cytological Structural Features. Acta Cytologica. 67(4). 403–412. 1 indexed citations
6.
7.
Yoshida, Chihiro, et al.. (2023). CD44v6 downregulation as a prognostic factor for distant recurrence in resected stage I lung adenocarcinomas. Clinical and Experimental Medicine. 23(8). 5191–5200.
8.
Oshima, Minoru, Keiichi Okano, Hideki Kamada, et al.. (2022). P53 immunolabeling in EUS‐FNA biopsy can predict low resection rate and early recurrence in resectable or borderline resectable pancreatic cancer treated with neoadjuvant therapy. Journal of Hepato-Biliary-Pancreatic Sciences. 30(6). 802–814. 6 indexed citations
9.
Tohi, Yoichiro, Ryou Ishikawa, Takuma Kato, et al.. (2022). Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study. International Journal of Clinical Oncology. 28(2). 299–305. 7 indexed citations
10.
11.
Nakashima, Nariyasu, Nobuyuki Kita, Hiroyuki Nakamura, et al.. (2022). IgG4-related lung disease with recurrent pulmonary lesions during steroid therapy and difficulty in differentiating from malignancy: a case report. Journal of Cardiothoracic Surgery. 17(1). 62–62. 1 indexed citations
12.
Ishikawa, Ryou, Kyuichi Kadota, Chihiro Yoshida, et al.. (2022). Prognostic impact of tumor-infiltrating lymphocytes and neutrophils in resected non-small cell lung carcinoma. Human Pathology. 125. 87–96. 5 indexed citations
13.
Kadota, Kyuichi, Chihiro Yoshida, Emi Ibuki, et al.. (2022). MMP-7 expression is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas. Lung Cancer. 175. 125–130. 7 indexed citations
14.
15.
Kato, Takuma, Ryou Ishikawa, Kenichi Tanaka, et al.. (2020). The Impact of Histopathological Features of Prostate Cancerous Lesions on Multiparametric Magnetic Resonance Imaging Findings using PI-RADS Version 2. Urology. 149. 174–180. 1 indexed citations
16.
Kanaji, Nobuhiro, et al.. (2019). Characteristics of multiple nodules in a patient with pulmonary Langerhans cell histiocytosis: A case report. World Journal of Clinical Cases. 7(17). 2519–2525. 2 indexed citations
17.
Kadota, Kyuichi, Yoshio Kushida, Ryou Ishikawa, et al.. (2018). Cribriform Subtype is an Independent Predictor of Recurrence and Survival After Adjustment for the Eighth Edition of TNM Staging System in Patients With Resected Lung Adenocarcinoma. Journal of Thoracic Oncology. 14(2). 245–254. 54 indexed citations
18.
Imachi, Hitomi, Toshihiro Kobayashi, Fumi Kikuchi, et al.. (2018). Thyroid stimulating hormone stimulates the expression of glucose transporter 2 via its receptor in pancreatic β cell line, INS-1 cells. Scientific Reports. 8(1). 1986–1986. 15 indexed citations
19.
Zheng, Xinyan, Satomi Takatsu, Ryou Ishikawa, & Hiroshi Hasegawa. (2017). Moderate intensity, exercise-induced catecholamine release in the preoptic area and anterior hypothalamus in rats is enhanced in a warm environment. Journal of Thermal Biology. 71. 123–127. 14 indexed citations
20.
Ishikawa, Ryou, Shuhei Horio, & Hirokazu Fukui. (2002). Insulin-induced up-regulation of histamine H1-receptors. Inflammation Research. 51(S1). 73–74. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rami Darwich Breakdown of academic impact, for papers by Thomas Aschacher Breakdown of academic impact, for papers by Alexandra Corina Faur Breakdown of academic impact, for papers by Emmy Yanagita Breakdown of academic impact, for papers by Peiqing Ma Breakdown of academic impact, for papers by Zhengming Zhu Breakdown of academic impact, for papers by Yuan Peng Breakdown of academic impact, for papers by Bofang Wang
Rankless by CCL
2026